Search Results - David Neal Franz
- Showing 1 - 20 results of 38
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Identification of S664 TSC2 Phosphorylation as a Marker for Extracellular Signal-Regulated Kinase–Mediated mTOR Activation in Tuberous Sclerosis and Human Cancer by Li Ma, Julie Teruya‐Feldstein, Pauline Bonner, Rosa Bernardi, David Neal Franz, David P. Witte, Carlos Cordón-Cardo, Pier Paolo Pandolfi
Published 2007Artigo -
7
Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012 by Jonathan Roth, E. Steve Roach, Ute Bartels, Sergiusz Jóźwiak, Mary Kay Koenig, Howard L. Weiner, David Neal Franz, Henry Z. Wang
Published 2013Artigo -
8
Analysis of TSC Cortical Tubers by Deep Sequencing of TSC1, TSC2 and KRAS Demonstrates that Small Second‐Hit Mutations in these Genes are Rare Events by Wei Qin, Jennifer A. Chan, Harry V. Vinters, Gary W. Mathern, David Neal Franz, Bruce E. Taillon, Pascal Bouffard, David J. Kwiatkowski
Published 2010Artigo -
9
A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC) by Johann Philipp Zöllner, David Neal Franz, Christoph Hertzberg, Rima Nabbout, Felix Rosenow, Matthias Sauter, Susanne Schubert‐Bast, Adelheid Wiemer‐Kruel, Adam Strzelczyk
Published 2020Revisão -
10
-
11
The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma by John J. Bissler, David Neal Franz, Michael Frost, Е. Д. Белоусова, E. Martina Bebin, Steven Sparagana, Noah Berkowitz, Antonia Ridolfi, J.C. Kingswood
Published 2017Artigo -
12
-
13
-
14
Superiority of Denaturing High Performance Liquid Chromatography over single‐stranded conformation and conformation‐sensitive gel electrophoresis for mutation detection in TSC2 by Yew-Sing Choy, Sandra L. Dabora, F. Scott Hall, Vijaya Ramesh, Yo Niida, David Neal Franz, Jolanta Kasprzyk‐Obara, Mary Pat Reeve, David J. Kwiatkowski
Published 1999Artigo -
15
Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2 by John J. Bissler, Klemens Budde, Matthias Sauter, David Neal Franz, Bernard A. Zonnenberg, Michael Frost, Е. Д. Белоусова, Noah Berkowitz, Antonia Ridolfi, J.C. Kingswood
Published 2018Artigo -
16
-
17
Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex by Wei Qin, Piotr Kozłowski, Bruce E. Taillon, Pascal Bouffard, Alison J. Holmes, Pasi A. Jänne, Susana Camposano, Elizabeth A. Thiele, David Neal Franz, David J. Kwiatkowski
Published 2010Artigo -
18
-
19
Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders by Darcy A. Krueger, Anjali Sadhwani, Anna W. Byars, Petrus J. de Vries, David Neal Franz, Vicky Whittemore, Rajna Filip‐Dhima, Donna S. Murray, Kush Kapur, Mustafa Şahin
Published 2017Artigo -
20
Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy by Hope S. Rugo, G. N. Hortobágyi, James C. Yao, Marianne Pavel, Alain Ravaud, David Neal Franz, François Ringeisen, Jorge D. Gallo, Nicolas Rouyrre, Oezlem Anak, Robert J. Motzer
Published 2016Revisão
Search Tools:
Related Subjects
Medicine
Tuberous sclerosis
Pathology
Internal medicine
Everolimus
Biology
Cancer research
Astrocytoma
PI3K/AKT/mTOR pathway
Psychiatry
Subependymal giant cell astrocytoma
Genetics
Adverse effect
Gastroenterology
Pediatrics
Epilepsy
Gene
Glioma
TSC1
TSC2
Alternative medicine
Angiomyolipoma
Apoptosis
Chemistry
Kidney
Placebo
Sirolimus
Urology
Biochemistry
Disease